Municipal Waste and Produced Water Update
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward produced-water operators such as WaterBridge.
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward produced-water operators such as WaterBridge.
Cal-Maine Foods to Cull 1.76 Million Birds After Florida Facility Tests Positive for Bird Flu $CALM
@Agent0088156721 That’s not what I was asking. $HUBG hasn’t filed any audited financials since the June 2025 10-Q and they just received another extension and remain listed. Re-read the questions I asked.
@MarkGroskyEsq @grok can the remaining ~$1.3B be reversed or no because it went through depreciation and amortization for $ZIM
$SGML
Perpetua Resources’ permitted Stibnite project holds 4.8 million gold ounces and a $2.9 billion EXIM loan, but faces single-asset…
Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…
Forestar trades near $22 versus $37.56 in tangible book value, with $657 million of cash and a potential D.R.
Entravision’s AdTech revenue rose 133% and EBIT 261% in Q3 as management weighs TV-station sales before its TelevisaUnivision agreement…
Bimergen Energy reported $3.0 million of Q3 revenue, below estimates, while a $3.6 million fair-value gain lifted net income to $2.4…
Sonida Senior Living owns 153 senior housing properties after a March 2026 merger doubled its scale, with aging-driven demand and tight…
Ondas reported $167.5 million in Q3 revenue but spent $562 million of cash, halved gross margin and fell below its $6 stop level.
Offshore Radar maps 160-plus listed offshore rigs, contracts, day rates and uncontracted capacity through 2029.
Sun Kwang (003100.KQ) raised grain market share from 25% to 38% as its founding family transferred 24% of the company to holding companies…
Travere Therapeutics' FILSPARI has two FDA approvals and is driving revenue growth, while TVTX shares have nearly tripled since August 2025.
ANAB · long AnaptysBio is pitched for a 50% to 80% return over four to six weeks after its April 2026 taxable spin-off of R&D-heavy operations.
Mereo Biopharma has two late-stage assets, seeks non-dilutive financing for alvelestat Phase 3 trials, and reports cash runway through 2027.
Instil Bio leased its 128,000-square-foot Tarzana life-sciences building to AstraZeneca for 15 years at $7.52 million annual rent,…
Red Cat’s Teal Drones is one of two remaining candidates for a $600 million to $1 billion-plus U.S.
JBG Smith trades at an estimated 40% discount to NAV, backed by National Landing multifamily assets, Amazon HQ demand and $1.3 billion of…
Monarch Casino trades at 7.2 times EBITDA with net cash, completed property upgrades and projected annual free cash flow of $120 million to…
Restaurant chains replaced 21 CEOs since 2021, as wage inflation, delivery, digital ordering and at-home competition reshape leadership…
IBio’s $20 million, debt-free valuation is a high-risk bet that it can partner a myostatin inhibitor for GLP-1-related muscle loss before…
Hayden Capital says Sea, AppLovin, New Oriental and Coinbase are gaining share as weaker rivals retrench, accelerating portfolio growth.
Sow Good trades below 6x NTM earnings after retiring debt and raising $12.8 million to expand freeze-dried candy capacity amid rapid…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.